Hummsa Bio

Rebuilding medicine for the diseases that define our future. We believe better therapeutics can mean longer, healthier lives, especially when we tackle the complex, chronic diseases that burden millions. That’s why we’re building a pipeline of oral, small-molecule therapies designed to do more than treat symptoms, they aim to reshape the way we manage metabolic and age-related diseases. Our lead program targets the GLP-1 receptor, but our vision reaches far beyond a single pathway. We’re backed by globally respected experts in endocrinology, metabolic disease, and translational medicine people who share our belief that rigorous, smart science can lead to lasting change. We’re still early. But we’re moving fast, advancing preclinical work, growing our pipeline, and laying the foundation for partnerships that matter. We’d love to connect with those who share our passion for doing the hard, meaningful work of building better medicines for the long haul.